Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8627 |
High Similarity |
NPD2532 |
Approved |
0.8627 |
High Similarity |
NPD2534 |
Approved |
0.8627 |
High Similarity |
NPD2533 |
Approved |
0.8616 |
High Similarity |
NPD7075 |
Discontinued |
0.86 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7819 |
Suspended |
0.8481 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8442 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8428 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8375 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8313 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8293 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8269 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD1934 |
Approved |
0.821 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8158 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8133 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8129 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8114 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8086 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8079 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8075 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8059 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8052 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8026 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8013 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7987 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7939 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7927 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7882 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.787 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5710 |
Approved |
0.784 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7716 |
Intermediate Similarity |
NPD920 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7684 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD919 |
Approved |
0.7676 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7662 |
Intermediate Similarity |
NPD943 |
Approved |
0.7647 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7614 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7613 |
Intermediate Similarity |
NPD447 |
Suspended |
0.761 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7602 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD37 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD6651 |
Approved |
0.756 |
Intermediate Similarity |
NPD4965 |
Approved |
0.756 |
Intermediate Similarity |
NPD4966 |
Approved |
0.756 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7483 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7474 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7446 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7435 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7394 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7394 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7375 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7354 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7354 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6535 |
Approved |
0.733 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7308 |
Intermediate Similarity |
NPD411 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7308 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.725 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7205 |
Intermediate Similarity |
NPD5404 |
Approved |
0.72 |
Intermediate Similarity |
NPD9268 |
Approved |
0.72 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7171 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7167 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7118 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7089 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7089 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7055
|
Intermediate Similarity |
NPD1471 |
Phase 3 |